Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05426083 · ClinicalTrials.gov registry record
Left Ventricular Physiological Effects of Veno-Arterial Extracorporeal Membrane Oxygenation Support During Cardiogenic Shock
A clinical trial of Acute Coronary Syndrome and Cardiogenic Shock, sponsored by University of Minnesota.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT05426083: Recruiting study of Acute Coronary Syndrome and Cardiogenic Shock, sponsored by University of Minnesota.
NCT05426083 is a study of Acute Coronary Syndrome and Cardiogenic Shock that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 200 participants, below the 2,717-participant average among 40 other Acute Coronary Syndrome trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05426083, a study of Acute Coronary Syndrome and Cardiogenic Shock, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
A Clinical Events Committee (CEC) will include Cardiac Surgery Professor and chief of cardiac surgery Rose Kelly MD, Professor of Medicine Ganesh Raveendran MD at the University of Minnesota who is the direction of Interventional Cardiology and Professor of Medicine at the University of Minnesota David Benditt. They will review and adjudicate serious and unexpected adverse events independently from the PI and co investigators.
Primary Outcome
Pressure-volume loops at the highest level of VA-ECMO support and the lowest level of VA-ECMO support.
Conditions Studied
Interventions
- OTHER Physiological Assessment
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2022-08-04 |
| Est. Completion | 2026-12-31 |
What NCT05426083 shows while recruiting
NCT05426083 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 2,717-participant average among 40 other Acute Coronary Syndrome trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Acute Coronary Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Physiological Assessment is the first listed.
NCT05426083 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05426083 about?
NCT05426083 is a clinical study titled "Left Ventricular Physiological Effects of Veno-Arterial Extracorporeal Membrane Oxygenation Support During Cardiogenic Shock". A Clinical Events Committee (CEC) will include Cardiac Surgery Professor and chief of cardiac surgery Rose Kelly MD, Professor of Medicine Ganesh Raveendran MD at the University of Minnesota who is the direction of Interventional Cardiology and Professor of Medicine at the University of Minnesota Da...
What is the current status of trial NCT05426083?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2022-08-04. Estimated completion is 2026-12-31.
What conditions does trial NCT05426083 study?
This clinical trial studies the following conditions: Acute Coronary Syndrome, Cardiogenic Shock.
What interventions are being tested in trial NCT05426083?
The interventions under investigation include: Physiological Assessment (OTHER).
Who is sponsoring clinical trial NCT05426083?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05426083 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Coronary Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05426083's enrollment target sits among peer trials
200 28th of 40 higher than 13 of 40 other Acute Coronary Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Coronary Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Polypill for Acute Coronary Syndrome
RECRUITING · Phase 2
-
Positive Emotions Following Acute Cardiac Events
RECRUITING · NA
-
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
RECRUITING · Phase 3
-
A Prospective Research Investigation of Ischemia Using MCG
RECRUITING
-
AngelMed Guardian® System PMA Post Approval Study
RECRUITING
-
Online Tai Chi Plus Fitbit After ACS
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI